Kamada (KMDA) vs Prothena (PRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Kamada (KMDA) has outperformed Prothena (PRTA) over the past year, gaining 18.6% versus a loss of 16.6%. Over five years, KMDA leads with a +49.7% price change compared with -86.6% for PRTA. Kamada is the larger company by market cap ($455.3 million vs $435.3 million), about 1.0 times the size.
Kamada pays a dividend yielding 3.17%, while Prothena does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KMDA | PRTA |
|---|---|---|
| Share price | $7.89 | $8.48 |
| Market cap | $455.33M | $435.34M |
| 1-day change | -2.71% | +5.74% |
| YTD return | +11.76% | -11.20% |
| 1-year return | +18.65% | -16.62% |
| 5-year return | +49.72% | -86.64% |
| P/E ratio (TTM) | 20.76 | — |
| Forward P/E | 13.68 | — |
| EPS (TTM) | $0.38 | $-0.82 |
| Dividend yield | 3.17% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| 52-week high | $9.35 | $11.80 |
| 52-week low | $6.55 | $7.73 |
| Distance from 52-week high | -15.61% | -28.14% |
| Average volume | 118.76K | 478.70K |
| Shares outstanding | 57.71M | 51.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KMDA has outperformed PRTA by 35.3 percentage points over the past year.
- Kamada offers a meaningfully higher dividend yield (3.17% vs 0.00%).
KMDA vs PRTA FAQ
Which is bigger, Kamada or Prothena?
Kamada (KMDA) is larger, with a market capitalization of $455.33M compared with $435.34M for Prothena (PRTA).
Which stock has performed better over the past year, KMDA or PRTA?
KMDA returned +18.65% over the past 12 months, compared with -16.62% for PRTA (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Kamada or Prothena?
Kamada pays a dividend yielding 3.17%, while Prothena does not currently pay a regular dividend.
Are Kamada and Prothena in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.